NAIVE: Quantification of Inspiratory Effort Through Nasal Pressure in Patients Undergoing Weaning From Invasive Mechanical Ventilation and Correlation With Clinical Outcomes

Sponsor
University of Modena and Reggio Emilia (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05282238
Collaborator
(none)
175
1
32
5.5

Study Details

Study Description

Brief Summary

Weaning from invasive mechanical ventilation (MV) constitutes a fundamental procedure in intensive care, covering up to 50% of time spent on ventilation (1). Endotracheal tube (ETT) removal might be an important but delicate step in intensive care setting. Failure and subsequent need for re-intubation can occur in up to 20% of cases leading to a significant increase in mortality rates (24%), longer hospital stay and prolonged need for ventilation. Comorbidities such as obesity, COPD and cardiac related diseases might further increase this risk reaching up to 60% of failure in extubation. In this scenario, accurate predictors of weaning failure are far welcomed. The recurrence of respiratory failure after extubation might considerably raise rates of failure, probably due to increased work of breathing in patients after ETT removal. Most recent guidelines on the use of non-invasive ventilation (NIV) suggest using NIV after ETT removal in subjects with high risk of failure. NIV could contribute to reduce work of breathing hence preventing the onset of respiratory failure after extubation. Therefore, measuring inspiratory effort and its variation in weaned patients might help in identifying patients with significant risk of failing extubation. Esophageal pressure swings (DeltaPES) can be measured through a nasogastric tube with a pressure transducer located in the inferior part of the esophagus. DeltaPES is an extremely precise and accurate method to quantify inspiratory effort, however its use in daily clinical practice is limited due to the invasive nature of the maneuver, elevated costs and need for considerable clinical training of operators. Physiological studies have shown a correlation between nasal pressure measured at nostril entrance and esophageal pressure (which in turn is a measure of respiratory effort .

Therefore, measuring nasal pressure could represent a method to quantify inspiratory effort non-invasively, proving to be useful in daily clinical practice.

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: Nasal pressure assessment

Study Design

Study Type:
Observational
Anticipated Enrollment :
175 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Quantification of Inspiratory Effort Through Nasal Pressure in Patients Undergoing Weaning From Invasive Mechanical Ventilation and Correlation With Clinical Outcomes
Anticipated Study Start Date :
May 1, 2022
Anticipated Primary Completion Date :
May 1, 2023
Anticipated Study Completion Date :
Dec 31, 2024

Outcome Measures

Primary Outcome Measures

  1. Weaning failure [48 hours]

    Weaning failure will be defined by need for re-intubation

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • candidates for endotracheal tube removal.
Exclusion Criteria:
  • Age under 18

  • Pregnancy

  • Patient unable or unwilling to sign informed consent

  • Neuromuscular diseases

  • Patient with compromised neurological state (Glasgow Coma Scale (GCS) under 14/15)

Contacts and Locations

Locations

Site City State Country Postal Code
1 Azienda Ospedaliero Universitaria Policlinico di Modena Modena Italy

Sponsors and Collaborators

  • University of Modena and Reggio Emilia

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Roberto Tonelli, Principal Investigator, University of Modena and Reggio Emilia
ClinicalTrials.gov Identifier:
NCT05282238
Other Study ID Numbers:
  • UModenaReggio15
First Posted:
Mar 16, 2022
Last Update Posted:
Apr 5, 2022
Last Verified:
Mar 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Roberto Tonelli, Principal Investigator, University of Modena and Reggio Emilia
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 5, 2022